Leaderboard

En | De
Sie sind hier: Respirationstrakt » Neoplasie 30. Juni 2025
Suchen
medline.ch
Neoplasie
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Allergische Rhinitis - Pollinosis
Asthma
Bronchitis
COPD
Interstitielle Pneumopathien
Lungenembolie
Neoplasie
Pleuraerkrankungen
Pneumonie
SARS
Schlaf- Apnoe-Syndrom
Tuberkulose
Zystische Fibrose
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 7443  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 148852  
   
Radiomic 'Stress Test': exploration of a deep learning radiomic model in a high-risk prospective lung nodule cohort.
BMJ Open Respir Res
Xiao D, Forero Y, Kammer MN, Chen H, Paez R, Heideman BE, Owoseeni O, Johnson I, Deppen SA, Grogan EL, Maldonado F.
PMID: 40579208 [PubMed - indexed for MEDLINE]


Sinonasal neuroendocrine carcinoma in a previously healthy young adult male.
BMJ Case Rep
Mølhave M, Hamilton-Dutoit S, Fjaeldstad AW.
PMID: 40579203 [PubMed - indexed for MEDLINE]


Impact of Thyroid Dose on Radiation-induced Hypothyroidism in Early Glottic Cancer Patients Undergoing Volumetric Modulated Arc Therapy.
In Vivo
Park HJ, Koo T, Cheong KH, Lee MY, Koh HK, Park Y.
PMID: 40579025 [PubMed - indexed for MEDLINE]


Identifying the Primary Tumor Site and Distinguishing False-positives in Patients With Elevated Serum Carcinoembryonic Antigen.
In Vivo
Satoh H, Sakamoto T, Takahashi Y, Miyazaki K, Inagawa S.
PMID: 40579007 [PubMed - indexed for MEDLINE]


The Usefulness of the Modified Advanced Lung Cancer Inflammation Index (mALI) as a Prognostic Factor in Patients With Esophageal Cancer who Have Undergone Curative Resection.
In Vivo
Yamamoto S, Aoyama T, Maezawa Y, Hashimoto I, Esashi R, Otani K, Nukada S, Ishiguro T, Shimada K, Kazama K, Numata K, Uchiyama M, Hatayama R, Tamagawa A, Saito A, Yukawa N.
PMID: 40578993 [PubMed - indexed for MEDLINE]


The significance of protein N-glycosylation in the pathogenesis of lung cancer and its clinical implications.
Cancer Lett
Huang Y, Song J, Chen J, Li F, Zhang Y, Yang JH.
PMID: 40578752 [PubMed - as supplied by publisher]


Adjuvant chemotherapy for stage IA-IIA non-squamous, non-small-cell lung cancer identified as molecular high-risk by a 14-gene expression profile (AIM-HIGH): an international, randomised, phase 3 trial.
Lancet Respir Med
Spigel DR, Westeel V, Anderson IC, Greillier L, Guisier F, Bylicki O, Badin FB, Rousseau-Bussac G, Deldycke C, Griesinger F, Bograd A, Zhong W, Le Treut J, Van Hulst S, Gandara DR, Reck M, Hoffknecht P, Gubens MA, Crowley J, von der Leyen H, Woodard GA, Jablons DM, Kratz JR, Mann MJ, AIM-HIGH investigators.
PMID: 40578381 [PubMed - as supplied by publisher]


Clinical benefit and cost of plasma-first next-generation sequencing in patients with newly diagnosed advanced non-small cell lung cancer in Ireland: The PLAN study.
Eur J Cancer
O'Reilly D, O'Grady A, Hayes C, Piggott L, Keane R, Fitzpatrick OM, Conroy M, Aretz NK, Synnott D, Dillon R, Dowling GP, Ryan DJ, O'Brien E, Morgan R, Breathnach O, Grogan L, Morris P, Greally M, Teo MY, Murphy A, Ryan G, Counihan I, Ryan C, Barrett H, O'Shea AM, Cuffe S, Korpanty G, Prior L, Barr MP, Finn S, O'Brien C, McCarron S, Cummins R, Toomey S, Dowling CM, Glavey S, Hennessy BT, Sorensen J, Bennett K, Nadarajan P, Doyle B, Naidoo J.
PMID: 40578048 [PubMed - as supplied by publisher]


Silver nanoparticles: Forging a new frontline in lung cancer therapy.
Biomater Adv
Raies S, Rehman U, Siddiqua A, Wahab S, Gupta G, Goh KW, Kesharwani P.
PMID: 40577936 [PubMed - as supplied by publisher]


A multi-institutional randomized phase III trial of lobectomy versus segmentectomy for radiologically solid-predominant non-small cell lung cancer with a ground-glass opacity and tumor diameter > 2 cm and ≤ 3 cm: JCOG2217 (STRONG).
Jpn J Clin Oncol
Mitome N, Hattori A, Suzuki K, Wakabayashi M, Sekino Y, Isaka T, Yotsukura M, Aokage K, Fukuda H, Watanabe SI.
PMID: 40577245 [PubMed - as supplied by publisher]


Precision-medicine management recommendations for advanced non-small cell lung cancer: expert consensus.
Future Oncol
Kourie HR, Bachouchi MA, Gamaz MM, Dawoud EA, Amir ZM, El Attar HA, Alrehaily SS, Zouein JF, Naim N, Hameedi AD, Alnaqqash MA, Mahfouz RAR, Masri S, Debs J, Barrou T, El Kadi H, Subbiah V, Penault-Llorca F.
PMID: 40577077 [PubMed - as supplied by publisher]


Rechallenge of immune checkpoint inhibitor after local therapy for immune checkpoint inhibitor-resistant non-small cell lung cancer.
Chin Clin Oncol
Hirano S, Fujita T, Takahashi H, Noda K, Yoshida N, Matsuda K, Shojima H, Shikano K, Amano H, Nakamura M, Onozawa M, Araki H, Aruga T, Nakamura S.
PMID: 40575966 [PubMed - indexed for MEDLINE]


Case Report: Do not diagnose lung cancer as pneumonia: continue to monitor a case of invasive mucinous adenocarcinoma as it progresses from small to large.
Front Med (Lausanne)
Zhang YN, Cao K, Yang Y, Wei T, Li MJ, Wei JX, Liu QL.
PMID: 40575565 [PubMed]


Prognostic analysis and association of the systemic immune-inflammatory index with immune checkpoint inhibitor pneumonitis in patients with non-small cell lung cancer.
Front Oncol
Cai M, Sun J, Wu J, Liu Y, Huang Y.
PMID: 40575174 [PubMed]


Exosomes in lung cancer: a role in early diagnosis.
Front Oncol
Zhou T, Ma H, Li Z, Xu Y, Zhao L.
PMID: 40575159 [PubMed]


Efficacy and safety of first-line PD-1/PD-L1 inhibitors combined with or without anti-angiogenesis therapy for extensive-stage small-cell lung cancer: a network meta-analysis.
Ther Adv Med Oncol
Zhou L, Li Y, Wang L, Chen K, Zhou S, Chen Y, Sun J, Tong Y, Fan Y.
PMID: 40574965 [PubMed]


Induction chemoimmunotherapy may achieve non-inferior outcomes to consolidation immunotherapy in patients with unresectable stage III NSCLC: a real-world multicenter retrospective study.
Front Immunol
Guan S, Wang Y, Liu Q, Yan M, Ren K, Wang J, Bi N, Zhao L.
PMID: 40574850 [PubMed - indexed for MEDLINE]


Clinical needs and pathology's answers in neuroendocrine neoplasms of the lung.
Pathologica
Pelosi G, Laffi A, Papotti M, Lantuejoul S, Scoazec JY, Gemelli M, Ricotta R, Harari S, Duregon E, Papa R, Sonzogni A, Bianchi F, Bruno A, Bassani B, Uccella S, Carnaghi C, Bertuzzi A.
PMID: 40574629 [PubMed - as supplied by publisher]


Promising Effectiveness of Combined Chemotherapy and Immunotherapy in Patients with Advanced Non-small Cell Lung Cancer: A Real-World Prospective Observational Study (CS-Lung-003).
Acta Med Okayama
Kanaji N, Nishii K, Tsubata Y, Nakao M, Okuno T, Okawa S, Takata K, Kodani M, Yamasaki M, Fujitaka K, Kubota T, Inoue M, Watanabe N, Hotta K, CS-Lung-003 Investigator.
PMID: 40574255 [PubMed - indexed for MEDLINE]


Efficacy and Safety of CT-Guided Patent Blue Injection to Localize Deep Pulmonary Nodules of the Thorax.
Medicina (Kaunas)
Lin CH, Huang TW, Hsu HH, Tsai WC, Ko KH.
PMID: 40572715 [PubMed - indexed for MEDLINE]


   
   Artikel 1 - 20 / 148852    Seite 1 von 7443  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

  Zeitfenster  
   

Sky right 1